vs
Side-by-side financial comparison of BELDEN INC. (BDC) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $720.1M, roughly 1.5× BELDEN INC.). BELDEN INC. runs the higher net margin — 9.4% vs -127.8%, a 137.2% gap on every dollar of revenue. On growth, BELDEN INC. posted the faster year-over-year revenue change (8.1% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $121.3M). Over the past eight quarters, BELDEN INC.'s revenue compounded faster (9.2% CAGR vs 1.3%).
Belden Inc. is an American, multinational, publicly traded company specializing in the design, manufacture, and distribution of end-to-end networking, security and connectivity products. The company serves the Industrial Automation Solutions, Smart Buildings and Broadband & 5G markets.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
BDC vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $720.1M | $1.1B |
| Net Profit | $67.9M | $-1.4B |
| Gross Margin | 36.6% | 32.6% |
| Operating Margin | 12.2% | -116.0% |
| Net Margin | 9.4% | -127.8% |
| Revenue YoY | 8.1% | -2.5% |
| Net Profit YoY | 16.3% | -3093.9% |
| EPS (diluted) | $1.70 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $720.1M | — | ||
| Q4 25 | $720.1M | $1.1B | ||
| Q3 25 | $698.2M | $1.0B | ||
| Q2 25 | $672.0M | $1.1B | ||
| Q1 25 | $624.9M | $1.0B | ||
| Q4 24 | $666.0M | $1.1B | ||
| Q3 24 | $654.9M | $1.1B | ||
| Q2 24 | $604.3M | $1.1B |
| Q1 26 | $67.9M | — | ||
| Q4 25 | $67.9M | $-1.4B | ||
| Q3 25 | $56.7M | $7.5M | ||
| Q2 25 | $61.0M | $-8.4M | ||
| Q1 25 | $51.9M | $-6.4M | ||
| Q4 24 | $58.4M | $-44.4M | ||
| Q3 24 | $53.7M | $-21.0M | ||
| Q2 24 | $49.0M | $-108.4M |
| Q1 26 | 36.6% | — | ||
| Q4 25 | 36.6% | 32.6% | ||
| Q3 25 | 37.7% | 36.1% | ||
| Q2 25 | 38.5% | 34.4% | ||
| Q1 25 | 39.3% | 37.6% | ||
| Q4 24 | 37.5% | 33.9% | ||
| Q3 24 | 37.3% | 37.2% | ||
| Q2 24 | 37.5% | 37.0% |
| Q1 26 | 12.2% | — | ||
| Q4 25 | 12.2% | -116.0% | ||
| Q3 25 | 10.9% | 7.0% | ||
| Q2 25 | 11.8% | 4.3% | ||
| Q1 25 | 11.6% | 4.5% | ||
| Q4 24 | 10.4% | 10.0% | ||
| Q3 24 | 11.5% | 7.4% | ||
| Q2 24 | 11.4% | -2.5% |
| Q1 26 | 9.4% | — | ||
| Q4 25 | 9.4% | -127.8% | ||
| Q3 25 | 8.1% | 0.7% | ||
| Q2 25 | 9.1% | -0.8% | ||
| Q1 25 | 8.3% | -0.6% | ||
| Q4 24 | 8.8% | -3.9% | ||
| Q3 24 | 8.2% | -1.9% | ||
| Q2 24 | 8.1% | -10.2% |
| Q1 26 | $1.70 | — | ||
| Q4 25 | $1.70 | $-10.23 | ||
| Q3 25 | $1.41 | $0.05 | ||
| Q2 25 | $1.53 | $-0.06 | ||
| Q1 25 | $1.27 | $-0.05 | ||
| Q4 24 | $1.41 | $-0.32 | ||
| Q3 24 | $1.30 | $-0.15 | ||
| Q2 24 | $1.19 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $389.9M | — |
| Total DebtLower is stronger | $1.3B | — |
| Stockholders' EquityBook value | $1.3B | $2.9B |
| Total Assets | — | $8.5B |
| Debt / EquityLower = less leverage | 1.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $389.9M | — | ||
| Q4 25 | $389.9M | — | ||
| Q3 25 | $314.3M | $432.1M | ||
| Q2 25 | $301.5M | $454.2M | ||
| Q1 25 | $259.0M | $409.9M | ||
| Q4 24 | $370.3M | $558.8M | ||
| Q3 24 | $323.0M | $1.5B | ||
| Q2 24 | $564.8M | $542.8M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.2B | $4.4B | ||
| Q2 25 | $1.2B | $4.5B | ||
| Q1 25 | $1.2B | $4.4B | ||
| Q4 24 | $1.3B | $4.3B | ||
| Q3 24 | $1.2B | $4.6B | ||
| Q2 24 | $1.2B | $4.5B |
| Q1 26 | — | — | ||
| Q4 25 | $3.5B | $8.5B | ||
| Q3 25 | $3.4B | $10.1B | ||
| Q2 25 | $3.4B | $10.1B | ||
| Q1 25 | $3.3B | $9.8B | ||
| Q4 24 | $3.3B | $9.6B | ||
| Q3 24 | $3.3B | $11.2B | ||
| Q2 24 | $3.5B | $10.4B |
| Q1 26 | 1.02× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $354.9M | $175.4M |
| Free Cash FlowOCF − Capex | $121.3M | $148.6M |
| FCF MarginFCF / Revenue | 16.8% | 13.4% |
| Capex IntensityCapex / Revenue | 18.9% | 2.4% |
| Cash ConversionOCF / Net Profit | 5.23× | — |
| TTM Free Cash FlowTrailing 4 quarters | $364.7M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $354.9M | — | ||
| Q4 25 | $160.4M | $175.4M | ||
| Q3 25 | $105.0M | $51.7M | ||
| Q2 25 | $82.0M | $75.9M | ||
| Q1 25 | $7.4M | $-64.5M | ||
| Q4 24 | $174.7M | $312.6M | ||
| Q3 24 | $91.7M | $42.2M | ||
| Q2 24 | $83.0M | $9.5M |
| Q1 26 | $121.3M | — | ||
| Q4 25 | $121.3M | $148.6M | ||
| Q3 25 | $65.3M | $29.8M | ||
| Q2 25 | $56.9M | $56.7M | ||
| Q1 25 | $-24.8M | $-90.0M | ||
| Q4 24 | $116.4M | $274.9M | ||
| Q3 24 | $67.2M | $15.1M | ||
| Q2 24 | $61.0M | $-18.9M |
| Q1 26 | 16.8% | — | ||
| Q4 25 | 16.8% | 13.4% | ||
| Q3 25 | 9.4% | 2.9% | ||
| Q2 25 | 8.5% | 5.4% | ||
| Q1 25 | -4.0% | -8.6% | ||
| Q4 24 | 17.5% | 24.2% | ||
| Q3 24 | 10.3% | 1.4% | ||
| Q2 24 | 10.1% | -1.8% |
| Q1 26 | 18.9% | — | ||
| Q4 25 | 5.4% | 2.4% | ||
| Q3 25 | 5.7% | 2.1% | ||
| Q2 25 | 3.7% | 1.8% | ||
| Q1 25 | 5.2% | 2.4% | ||
| Q4 24 | 8.8% | 3.3% | ||
| Q3 24 | 3.7% | 2.5% | ||
| Q2 24 | 3.6% | 2.7% |
| Q1 26 | 5.23× | — | ||
| Q4 25 | 2.36× | — | ||
| Q3 25 | 1.85× | 6.89× | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 2.99× | — | ||
| Q3 24 | 1.71× | — | ||
| Q2 24 | 1.69× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BDC
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
